Ohio Public Employees Retirement System (OPERS)’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.71K Buy
309
+149
+93% +$4.4K ﹤0.01% 2266
2026
Q1
$3.96K Buy
+160
New +$3.81K ﹤0.01% 2284
2022
Q3
Sell
-29,132
Closed -$204K 2026
2022
Q2
$204K Sell
29,132
-59,526
-67% -$437K ﹤0.01% 1478
2022
Q1
$735K Hold
88,658
﹤0.01% 1286
2021
Q4
$600K Buy
+88,658
New +$583K ﹤0.01% 1321

Other funds holding CPRX

Ohio Public Employees Retirement System (OPERS)'s CPRX Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) increased its Catalyst Pharmaceutical (CPRX) stake by 93% in Q2 2026, buying an estimated $4.4K and bringing the position to 309 shares worth $9.71K. The position accounts for ﹤0.01% of the portfolio, ranked #2266.

Ohio Public Employees Retirement System (OPERS) first reported a position in CPRX in Q4 2021 and has held it in 5 quarters since. The position peaked at $735K in Q1 2022. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Ohio Public Employees Retirement System (OPERS) held 309 shares of Catalyst Pharmaceutical worth $9.71K as of Q2 2026.
  • Ohio Public Employees Retirement System (OPERS) bought 149 Catalyst Pharmaceutical shares in Q2 2026, an estimated $4.4K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #2266 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Catalyst Pharmaceutical in Q4 2021 and has held it in 5 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Catalyst Pharmaceutical position peaked at $735K in Q1 2022.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.